PEAK6’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.68M Buy
10,100
+9,200
+1,022% +$5.9M 0.01% 838
2025
Q4
$609K Sell
900
-22,300
-96% -$15.2M ﹤0.01% 2009
2025
Q3
$14.8M Buy
23,200
+8,000
+53% +$4.86M 0.02% 529
2025
Q2
$8.15M Buy
+15,200
New +$7.27M 0.02% 721
2025
Q1
Sell
-4,200
Closed -$1.74M 3269
2024
Q4
$1.74M Buy
+4,200
New +$1.84M ﹤0.01% 1498

Other funds holding IDXX

PEAK6's IDXX Position: Q1 2026 in Review

PEAK6 increased its Idexx Laboratories (IDXX) stake by 31% in Q1 2026, buying an estimated $550K and bringing the position to 3,640 shares worth $2.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1352.

PEAK6 first reported a position in IDXX in Q4 2024 and has held it in 6 quarters since. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • PEAK6 held 3,640 shares of Idexx Laboratories worth $2.05M as of Q1 2026.
  • PEAK6 bought 858 Idexx Laboratories shares in Q1 2026, an estimated $550K.
  • Idexx Laboratories made up ﹤0.01% of PEAK6's portfolio in Q1 2026, its #1352 holding.
  • PEAK6 first reported a position in Idexx Laboratories in Q4 2024 and has held it in 6 quarters since.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.